
### [NCIT:C8014](http://purl.obolibrary.org/obo/NCIT_C8014)
**Label:** Lip Basal Cell Carcinoma

**Subclasses:** [NCIT:C8209](http://purl.obolibrary.org/obo/NCIT_C8209) (Stage IV Lip Basal Cell Carcinoma), [NCIT:C8205](http://purl.obolibrary.org/obo/NCIT_C8205) (Stage III Lip Basal Cell Carcinoma), [NCIT:C8201](http://purl.obolibrary.org/obo/NCIT_C8201) (Stage II Lip Basal Cell Carcinoma), [NCIT:C5893](http://purl.obolibrary.org/obo/NCIT_C5893) (Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7), [NCIT:C8213](http://purl.obolibrary.org/obo/NCIT_C8213) (Recurrent Lip Basal Cell Carcinoma), [NCIT:C8197](http://purl.obolibrary.org/obo/NCIT_C8197) (Stage I Lip Basal Cell Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) and (not ([NCIT:C36783](http://purl.obolibrary.org/obo/NCIT_C36783) (Malignant Non-Cutaneous Basaloid Cell))) 55.00%
- Thing 53.58%
- [NCIT:C60783](http://purl.obolibrary.org/obo/NCIT_C60783) (Malignant Cutaneous Basaloid Cell) 52.50%
- [NCIT:C36781](http://purl.obolibrary.org/obo/NCIT_C36781) (Neoplastic Cutaneous Basaloid Cell) 52.50%
- [NCIT:C36781](http://purl.obolibrary.org/obo/NCIT_C36781) (Neoplastic Cutaneous Basaloid Cell) and [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) 52.50%
- [NCIT:C36759](http://purl.obolibrary.org/obo/NCIT_C36759) (Neoplastic Basaloid Cell) 46.23%
- [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) 45.82%
- [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) and (not ([NCIT:C40311](http://purl.obolibrary.org/obo/NCIT_C40311) (Vulvar Syringoma))) 45.82%
- [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) and (not ([NCIT:C40309](http://purl.obolibrary.org/obo/NCIT_C40309) (Vulvar Sebaceous Carcinoma))) 45.82%
- [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) and (not ([NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma))) 45.82%
- [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) and (not ([NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma))) 45.82%
- [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) and (not ([NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma))) 45.82%
- [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) and (not ([NCIT:C40301](http://purl.obolibrary.org/obo/NCIT_C40301) (Adenoma of Minor Vestibular Glands))) 45.82%
- [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) and (not ([NCIT:C40299](http://purl.obolibrary.org/obo/NCIT_C40299) (Bartholin Gland Adenoma))) 45.82%
- [NCIT:C62227](http://purl.obolibrary.org/obo/NCIT_C62227) (Malignant Basaloid Cell) and (not ([NCIT:C40298](http://purl.obolibrary.org/obo/NCIT_C40298) (Bartholin Gland Small Cell Carcinoma))) 45.82%


